home / stock / lvzpf / lvzpf news
2023-03-20 01:10:00 ET Summary Livzon entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease (GERD) therapy from Onconic Therapeutics of Korea. Gracell Biotech announced in a press release that it had entered an unusual, non-exclusive global deal ...
Deals and Financings Ocumension [HK:1477], a Shanghai ophthalmic pharma, completed a $184 million Hong Kong IPO and climbed 152% in its first trading session, giving the company a valuation of about $2.5 billion (see story ). Founded in 2017, Ocumension was incubated by 6 Dimensions Capital...
New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cephradine Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the report is to offer updates and ...
News, Short Squeeze, Breakout and More Instantly...
Livzon Pharmaceutical Group Inc Company Name:
LVZPF Stock Symbol:
OTCMKTS Market:
New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cephradine Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the report is to offer updates and ...